First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 182.1 USD 0.97% Market Closed
Updated: Mar 29, 2024

Relative Value

The Relative Value of one ABBV stock under the Base Case scenario is 133.56 USD. Compared to the current market price of 182.1 USD, Abbvie Inc is Overvalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABBV Relative Value
Base Case
133.56 USD
Overvaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
61
Median 3Y
4.4
Median 5Y
4
Industry
8.2
Forward
5.8
vs History
0
vs Industry
2
Median 3Y
28.1
Median 5Y
22.3
Industry
26
Forward
15.9
vs History
0
vs Industry
10
Median 3Y
10.3
Median 5Y
9.8
Industry
21.5
vs History
0
vs Industry
8
Median 3Y
11.3
Median 5Y
10.3
Industry
24.3
vs History
0
vs Industry
2
Median 3Y
16.2
Median 5Y
14.3
Industry
2.7
vs History
0
vs Industry
48
Median 3Y
5.3
Median 5Y
5.1
Industry
7.4
Forward
6.5
vs History
0
vs Industry
41
Median 3Y
7.7
Median 5Y
7.4
Industry
9.4
vs History
6
vs Industry
9
Median 3Y
10.8
Median 5Y
10.7
Industry
4.2
Forward
13.5
vs History
0
vs Industry
6
Median 3Y
15.6
Median 5Y
15.4
Industry
4.3
Forward
14.4
vs History
0
vs Industry
9
Median 3Y
12.8
Median 5Y
12.4
Industry
5.3
vs History
0
vs Industry
8
Median 3Y
13.3
Median 5Y
12.9
Industry
3.3
vs History
0
vs Industry
36
Median 3Y
2.8
Median 5Y
2.9
Industry
5

Multiples Across Competitors

ABBV Competitors Multiples
Abbvie Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbvie Inc
NYSE:ABBV
321.6B USD 5.9 66.7 14.3 21.8
US
Amgen Inc
NASDAQ:AMGN
152.2B USD 5.4 22.7 16.7 25
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
107.7B USD 10.9 29.8 23.9 25.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.3B USD 8 26.6 18 19.8
US
Gilead Sciences Inc
NASDAQ:GILD
91.3B USD 3.4 16.1 9.6 12.8
AU
CSL Ltd
ASX:CSL
139.1B AUD 6.4 36.7 22.1 27.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
40.7B USD 5.9 -8.6 -9 -7.7
US
Biogen Inc
NASDAQ:BIIB
31.2B USD 3.2 26.9 14.5 18
KR
Celltrion Inc
KRX:068270
41.5T KRW 18 68.8 43.2 56.7
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Discover More